Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Multiple Myeloma 2Lymphoma, Non-Hodgkin 2Spondylitis, Ankylosing 1Skin Neoplasms 1Prostatic Neoplasms 1Pain, Postoperative 1Lymphoma, Follicular 1Hodgkin Disease 1Chronic Pain 1Acute Pain 1

Interventions

Bupivacaine 32Ropivacaine 19Dexmedetomidine 19Saline Solution 18Morphine 12Ketamine 12Sodium Chloride 10Acetaminophen 10Pregabalin 9Lidocaine 9Control Groups 9Injections, Epidural 5Dexamethasone 5Surgical Procedures, Operative 4Gabapentin 4Epinephrine 4Anesthetics, Local 4Anesthesia, General 4Analgesia, Patient-Controlled 4parecoxib 3oxycodone-acetaminophen 3Tea 3Midazolam 3Ketorolac 3Fentanyl 3Esketamine 3Dental Occlusion 3Anti-Inflammatory Agents, Non-Steroidal 3Analgesics, Opioid 3Vitamins 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pain, Postoperative × Meloxicam × Clear all
NCT07200544 2025-12-15

Meloxicam in Mohs Micrographic Surgery

University of Oklahoma

Phase 4 Recruiting
300 enrolled
Dermatologic

Pain, Postoperative, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡